INTRODUCTION
Depression and acute stress reaction (ASR) are the most common diagnoses for suicide attempts (1, 2) . ASR is a diagnosis given immediately following the experience of an exceptional mental or physical stress (1) . ASR increases suicide risk, and subjects with ASR and coexisting depression or substance abuse have elevated suicide rates than expected based on the independent effects of these conditions (3, 4) . Increases in circulating leukocytes in response to acute psychological stress or short-term intensive exercise is a well-documented phenomenon (5) . The effects of stress on circulating white blood cells (WBCs) have been experimentally studied in a number of animal species and or general increases in total WBCs, has been occasionally used as a measure of stress (6, 7) . volume (MPV) are increased in patients with depression (8) (9) (10) . ASR is often seen with depression, and stress-related hormones may fulfil an important role in acute arterial thrombosis by increasing platelet aggregation (2, 4, 11) .
Altered platelet function is observed in patients with depression (3). Platelet aggregation and mean platelet
To the best of our knowledge, no study has examined the association between ASR and hematological changes.
Therefore, the current study aimed to examine the association between ASR and the number of leukocytes and platelets in a hospital-based population. We hypothesized that ASR would be associated with a higher number of leukocytes compared with healthy adults without a diagnosis of ASR. The second objective was to examine MPV, which is a practical indicator of platelet activity and platelet count, in patients with ASR in comparison with healthy volunteers (12, 13) . Additionally, we examined medications taken following suicide attempts as modifiers of these associations.
MATERIALS AND METHODS

Patients
The study was conducted in an emergency clinic from 
ASR Diagnosis
The diagnosis of ASR was assessed through a semistructured clinical interview. According to the ICD-10
Classification, the symptoms of acute stress reaction must be present within 1 hour of the stressful or traumatic event and include one autonomic arousal symptom (e.g.
sweating, heart palpitations or shaking). In addition, symptoms from three of the following categories must be present: chest and abdomen symptoms (e.g. difficulty in breathing, feeling of choking or chest pain), brain and mind symptoms (e.g. feeling dizzy, feeling that objects are unreal or fear of dying), general symptoms (e.g. numbness or chills), muscle and mental tension symptoms and other non-specific symptoms (e.g. being easily startled, difficulty concentrating or irritability).
Biochemical Measurements
Blood samples were drawn within 3 hours after ASR i.e. suicide. Soon after, acute treatment protocols were applied in emergency rooms. After 3 to 5 days, blood samples were redrawn from the patients. Table 2 . At the 2 nd measurements, the platelet count was lower in patients as seen in Table 1 (p=0.001). The platelet count was found to be significantly decreased compared with the value of controls after the 2 nd measurements in patients who took anti-depressants for suicide (p=0.003).
There was also a significant decline in platelet count of patients who took antidepressants for suicide in comparison of 2 measurements (p=0.028). Inhibition of platelet aggregation by SSRIs in response to ADP followed by inhibition of the reuptake of serotonin into platelets results in reduced platelet aggregability (28) (29) (30) . In our study, we assessed platelet activity by measuring platelet count and MPV. Our findings were similar to previous studies suggesting that antidepressant treatment reduces platelet (hyper)activity (10, 24, 31, 32) .
DISCUSSION
The results of the present study also indicate that highdose SSRIs cause a decrease in the size and number of platelets in patients with ASR. Our findings provide evidence that high concentrations of SSRIs inhibit platelet activity within a short time period (within 3-5 days).
In summary, we believe we are the first to use MPV and platelet count as indicators of platelet activity in patients with ASR. We found that patients with ASR did not exhibit increased platelet activity, but our findings supported the antiplatelet affects of antidepressants, and this effect continued during subsequent days.
